Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Dosing at the first session will be 15 mg/70 kg. For the second session participants will either remain at the initial dose, or increase to 25 mg/70 kg at the discretion of the study team.